About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Neoantigen Cancer Vaccine Market Analysis, Size, Report to 2030

Neoantigen Cancer Vaccine Market

Neoantigen Cancer Vaccine Market Size, Share & Trends Analysis Report By Product (Personalised neo-antigen vaccine, Off-the-shelf neoantigen vaccine), By Neoantigen Type (Synthetic Long Peptide, Nucleic acid, Dendritic cell, Tumour cell), By Route of Administration (Intravenous, Intramuscular, Transdermal, Others), By Cell (Autologous, Allogenic), By Technology (RNA Sequencing, Whole Genome Sequencing, HLA Typing), By Delivery Mechanism (Liposomes, Virosomes, Gene gun, Electroporation, Others), By Application (Lung, Melanoma, Gastrointestinal, Brain cancer, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRHI2008DR
Study Period 2018-2030 CAGR 76%
Historical Period 2018-2020 Forecast Period 2022-2030
Base Year 2021 Base Year Market Size USD XX Billion
Forecast Year 2030 Forecast Year Market Size USD 1.38 Billion
Largest Market North America Fastest Growing Market Asia Pacific
Show More
Buy Now
File Formats
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Neoantigen Cancer Vaccine Market, By Product (2020-2030)
    1. Personalised neo-antigen vaccine
    2. Off-the-shelf neoantigen vaccine
  2. Neoantigen Cancer Vaccine Market, By Neoantigen Type (2020-2030)
    1. Synthetic Long Peptide
    2. Nucleic acid
    3. Dendritic cell
    4. Tumour cell
  3. Neoantigen Cancer Vaccine Market, By Route of Administration (2020-2030)
    1. Intravenous
    2. Intramuscular
    3. Transdermal
    4. Others
  4. Neoantigen Cancer Vaccine Market, By Cell (2020-2030)
    1. Autologous
    2. Allogenic
  5. Neoantigen Cancer Vaccine Market, By Technology (2020-2030)
    1. RNA Sequencing
    2. Whole Genome Sequencing
    3. HLA Typing
  6. Neoantigen Cancer Vaccine Market, By Delivery Mechanism (2020-2030)
    1. Liposomes
    2. Virosomes
    3. Gene gun
    4. Electroporation
    5. Others
  7. Neoantigen Cancer Vaccine Market, By Application (2020-2030)
    1. Lung
    2. Melanoma
    3. Gastrointestinal
    4. Brain cancer
    5. Others
    1. North America
      1. North America Neoantigen Cancer Vaccine Market, By Product
        1. Personalised neo-antigen vaccine
          1. Off-the-shelf neoantigen vaccine
          2. North America Neoantigen Cancer Vaccine Market, By Neoantigen Type
            1. Synthetic Long Peptide
              1. Nucleic acid
                1. Dendritic cell
                  1. Tumour cell
                  2. North America Neoantigen Cancer Vaccine Market, By Route of Administration
                    1. Intravenous
                      1. Intramuscular
                        1. Transdermal
                          1. Others
                          2. North America Neoantigen Cancer Vaccine Market, By Cell
                            1. Autologous
                              1. Allogenic
                              2. North America Neoantigen Cancer Vaccine Market, By Technology
                                1. RNA Sequencing
                                  1. Whole Genome Sequencing
                                    1. HLA Typing
                                    2. North America Neoantigen Cancer Vaccine Market, By Delivery Mechanism
                                      1. Liposomes
                                        1. Virosomes
                                          1. Gene gun
                                            1. Electroporation
                                              1. Others
                                              2. North America Neoantigen Cancer Vaccine Market, By Application
                                                1. Lung
                                                  1. Melanoma
                                                    1. Gastrointestinal
                                                      1. Brain cancer
                                                        1. Others
                                                        2. U.S.
                                                          1. U.S. Neoantigen Cancer Vaccine Market, By Product
                                                            1. Personalised neo-antigen vaccine
                                                              1. Off-the-shelf neoantigen vaccine
                                                              2. U.S. Neoantigen Cancer Vaccine Market, By Neoantigen Type
                                                                1. Synthetic Long Peptide
                                                                  1. Nucleic acid
                                                                    1. Dendritic cell
                                                                      1. Tumour cell
                                                                      2. U.S. Neoantigen Cancer Vaccine Market, By Route of Administration
                                                                        1. Intravenous
                                                                          1. Intramuscular
                                                                            1. Transdermal
                                                                              1. Others
                                                                              2. U.S. Neoantigen Cancer Vaccine Market, By Cell
                                                                                1. Autologous
                                                                                  1. Allogenic
                                                                                  2. U.S. Neoantigen Cancer Vaccine Market, By Technology
                                                                                    1. RNA Sequencing
                                                                                      1. Whole Genome Sequencing
                                                                                        1. HLA Typing
                                                                                        2. U.S. Neoantigen Cancer Vaccine Market, By Delivery Mechanism
                                                                                          1. Liposomes
                                                                                            1. Virosomes
                                                                                              1. Gene gun
                                                                                                1. Electroporation
                                                                                                  1. Others
                                                                                                  2. U.S. Neoantigen Cancer Vaccine Market, By Application
                                                                                                    1. Lung
                                                                                                      1. Melanoma
                                                                                                        1. Gastrointestinal
                                                                                                          1. Brain cancer
                                                                                                            1. Others
                                                                                                          2. Canada
                                                                                                        2. Europe
                                                                                                          1. Europe Neoantigen Cancer Vaccine Market, By Product
                                                                                                            1. Personalised neo-antigen vaccine
                                                                                                              1. Off-the-shelf neoantigen vaccine
                                                                                                              2. Europe Neoantigen Cancer Vaccine Market, By Neoantigen Type
                                                                                                                1. Synthetic Long Peptide
                                                                                                                  1. Nucleic acid
                                                                                                                    1. Dendritic cell
                                                                                                                      1. Tumour cell
                                                                                                                      2. Europe Neoantigen Cancer Vaccine Market, By Route of Administration
                                                                                                                        1. Intravenous
                                                                                                                          1. Intramuscular
                                                                                                                            1. Transdermal
                                                                                                                              1. Others
                                                                                                                              2. Europe Neoantigen Cancer Vaccine Market, By Cell
                                                                                                                                1. Autologous
                                                                                                                                  1. Allogenic
                                                                                                                                  2. Europe Neoantigen Cancer Vaccine Market, By Technology
                                                                                                                                    1. RNA Sequencing
                                                                                                                                      1. Whole Genome Sequencing
                                                                                                                                        1. HLA Typing
                                                                                                                                        2. Europe Neoantigen Cancer Vaccine Market, By Delivery Mechanism
                                                                                                                                          1. Liposomes
                                                                                                                                            1. Virosomes
                                                                                                                                              1. Gene gun
                                                                                                                                                1. Electroporation
                                                                                                                                                  1. Others
                                                                                                                                                  2. Europe Neoantigen Cancer Vaccine Market, By Application
                                                                                                                                                    1. Lung
                                                                                                                                                      1. Melanoma
                                                                                                                                                        1. Gastrointestinal
                                                                                                                                                          1. Brain cancer
                                                                                                                                                            1. Others
                                                                                                                                                            2. U.K.
                                                                                                                                                              1. U.K. Neoantigen Cancer Vaccine Market, By Product
                                                                                                                                                                1. Personalised neo-antigen vaccine
                                                                                                                                                                  1. Off-the-shelf neoantigen vaccine
                                                                                                                                                                  2. U.K. Neoantigen Cancer Vaccine Market, By Neoantigen Type
                                                                                                                                                                    1. Synthetic Long Peptide
                                                                                                                                                                      1. Nucleic acid
                                                                                                                                                                        1. Dendritic cell
                                                                                                                                                                          1. Tumour cell
                                                                                                                                                                          2. U.K. Neoantigen Cancer Vaccine Market, By Route of Administration
                                                                                                                                                                            1. Intravenous
                                                                                                                                                                              1. Intramuscular
                                                                                                                                                                                1. Transdermal
                                                                                                                                                                                  1. Others
                                                                                                                                                                                  2. U.K. Neoantigen Cancer Vaccine Market, By Cell
                                                                                                                                                                                    1. Autologous
                                                                                                                                                                                      1. Allogenic
                                                                                                                                                                                      2. U.K. Neoantigen Cancer Vaccine Market, By Technology
                                                                                                                                                                                        1. RNA Sequencing
                                                                                                                                                                                          1. Whole Genome Sequencing
                                                                                                                                                                                            1. HLA Typing
                                                                                                                                                                                            2. U.K. Neoantigen Cancer Vaccine Market, By Delivery Mechanism
                                                                                                                                                                                              1. Liposomes
                                                                                                                                                                                                1. Virosomes
                                                                                                                                                                                                  1. Gene gun
                                                                                                                                                                                                    1. Electroporation
                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                      2. U.K. Neoantigen Cancer Vaccine Market, By Application
                                                                                                                                                                                                        1. Lung
                                                                                                                                                                                                          1. Melanoma
                                                                                                                                                                                                            1. Gastrointestinal
                                                                                                                                                                                                              1. Brain cancer
                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                              2. Germany
                                                                                                                                                                                                              3. France
                                                                                                                                                                                                              4. Spain
                                                                                                                                                                                                              5. Italy
                                                                                                                                                                                                              6. Russia
                                                                                                                                                                                                              7. Nordic
                                                                                                                                                                                                              8. Benelux
                                                                                                                                                                                                              9. Rest of Europe
                                                                                                                                                                                                            2. APAC
                                                                                                                                                                                                              1. APAC Neoantigen Cancer Vaccine Market, By Product
                                                                                                                                                                                                                1. Personalised neo-antigen vaccine
                                                                                                                                                                                                                  1. Off-the-shelf neoantigen vaccine
                                                                                                                                                                                                                  2. APAC Neoantigen Cancer Vaccine Market, By Neoantigen Type
                                                                                                                                                                                                                    1. Synthetic Long Peptide
                                                                                                                                                                                                                      1. Nucleic acid
                                                                                                                                                                                                                        1. Dendritic cell
                                                                                                                                                                                                                          1. Tumour cell
                                                                                                                                                                                                                          2. APAC Neoantigen Cancer Vaccine Market, By Route of Administration
                                                                                                                                                                                                                            1. Intravenous
                                                                                                                                                                                                                              1. Intramuscular
                                                                                                                                                                                                                                1. Transdermal
                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                  2. APAC Neoantigen Cancer Vaccine Market, By Cell
                                                                                                                                                                                                                                    1. Autologous
                                                                                                                                                                                                                                      1. Allogenic
                                                                                                                                                                                                                                      2. APAC Neoantigen Cancer Vaccine Market, By Technology
                                                                                                                                                                                                                                        1. RNA Sequencing
                                                                                                                                                                                                                                          1. Whole Genome Sequencing
                                                                                                                                                                                                                                            1. HLA Typing
                                                                                                                                                                                                                                            2. APAC Neoantigen Cancer Vaccine Market, By Delivery Mechanism
                                                                                                                                                                                                                                              1. Liposomes
                                                                                                                                                                                                                                                1. Virosomes
                                                                                                                                                                                                                                                  1. Gene gun
                                                                                                                                                                                                                                                    1. Electroporation
                                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                                      2. APAC Neoantigen Cancer Vaccine Market, By Application
                                                                                                                                                                                                                                                        1. Lung
                                                                                                                                                                                                                                                          1. Melanoma
                                                                                                                                                                                                                                                            1. Gastrointestinal
                                                                                                                                                                                                                                                              1. Brain cancer
                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                2. China
                                                                                                                                                                                                                                                                  1. China Neoantigen Cancer Vaccine Market, By Product
                                                                                                                                                                                                                                                                    1. Personalised neo-antigen vaccine
                                                                                                                                                                                                                                                                      1. Off-the-shelf neoantigen vaccine
                                                                                                                                                                                                                                                                      2. China Neoantigen Cancer Vaccine Market, By Neoantigen Type
                                                                                                                                                                                                                                                                        1. Synthetic Long Peptide
                                                                                                                                                                                                                                                                          1. Nucleic acid
                                                                                                                                                                                                                                                                            1. Dendritic cell
                                                                                                                                                                                                                                                                              1. Tumour cell
                                                                                                                                                                                                                                                                              2. China Neoantigen Cancer Vaccine Market, By Route of Administration
                                                                                                                                                                                                                                                                                1. Intravenous
                                                                                                                                                                                                                                                                                  1. Intramuscular
                                                                                                                                                                                                                                                                                    1. Transdermal
                                                                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                                                                      2. China Neoantigen Cancer Vaccine Market, By Cell
                                                                                                                                                                                                                                                                                        1. Autologous
                                                                                                                                                                                                                                                                                          1. Allogenic
                                                                                                                                                                                                                                                                                          2. China Neoantigen Cancer Vaccine Market, By Technology
                                                                                                                                                                                                                                                                                            1. RNA Sequencing
                                                                                                                                                                                                                                                                                              1. Whole Genome Sequencing
                                                                                                                                                                                                                                                                                                1. HLA Typing
                                                                                                                                                                                                                                                                                                2. China Neoantigen Cancer Vaccine Market, By Delivery Mechanism
                                                                                                                                                                                                                                                                                                  1. Liposomes
                                                                                                                                                                                                                                                                                                    1. Virosomes
                                                                                                                                                                                                                                                                                                      1. Gene gun
                                                                                                                                                                                                                                                                                                        1. Electroporation
                                                                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                                                                          2. China Neoantigen Cancer Vaccine Market, By Application
                                                                                                                                                                                                                                                                                                            1. Lung
                                                                                                                                                                                                                                                                                                              1. Melanoma
                                                                                                                                                                                                                                                                                                                1. Gastrointestinal
                                                                                                                                                                                                                                                                                                                  1. Brain cancer
                                                                                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                                                                                  2. Korea
                                                                                                                                                                                                                                                                                                                  3. Japan
                                                                                                                                                                                                                                                                                                                  4. India
                                                                                                                                                                                                                                                                                                                  5. Australia
                                                                                                                                                                                                                                                                                                                  6. Taiwan
                                                                                                                                                                                                                                                                                                                  7. South East Asia
                                                                                                                                                                                                                                                                                                                  8. Rest of Asia-Pacific
                                                                                                                                                                                                                                                                                                                2. Middle East and Africa
                                                                                                                                                                                                                                                                                                                  1. Middle East and Africa Neoantigen Cancer Vaccine Market, By Product
                                                                                                                                                                                                                                                                                                                    1. Personalised neo-antigen vaccine
                                                                                                                                                                                                                                                                                                                      1. Off-the-shelf neoantigen vaccine
                                                                                                                                                                                                                                                                                                                      2. Middle East and Africa Neoantigen Cancer Vaccine Market, By Neoantigen Type
                                                                                                                                                                                                                                                                                                                        1. Synthetic Long Peptide
                                                                                                                                                                                                                                                                                                                          1. Nucleic acid
                                                                                                                                                                                                                                                                                                                            1. Dendritic cell
                                                                                                                                                                                                                                                                                                                              1. Tumour cell
                                                                                                                                                                                                                                                                                                                              2. Middle East and Africa Neoantigen Cancer Vaccine Market, By Route of Administration
                                                                                                                                                                                                                                                                                                                                1. Intravenous
                                                                                                                                                                                                                                                                                                                                  1. Intramuscular
                                                                                                                                                                                                                                                                                                                                    1. Transdermal
                                                                                                                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                                                                                                                      2. Middle East and Africa Neoantigen Cancer Vaccine Market, By Cell
                                                                                                                                                                                                                                                                                                                                        1. Autologous
                                                                                                                                                                                                                                                                                                                                          1. Allogenic
                                                                                                                                                                                                                                                                                                                                          2. Middle East and Africa Neoantigen Cancer Vaccine Market, By Technology
                                                                                                                                                                                                                                                                                                                                            1. RNA Sequencing
                                                                                                                                                                                                                                                                                                                                              1. Whole Genome Sequencing
                                                                                                                                                                                                                                                                                                                                                1. HLA Typing
                                                                                                                                                                                                                                                                                                                                                2. Middle East and Africa Neoantigen Cancer Vaccine Market, By Delivery Mechanism
                                                                                                                                                                                                                                                                                                                                                  1. Liposomes
                                                                                                                                                                                                                                                                                                                                                    1. Virosomes
                                                                                                                                                                                                                                                                                                                                                      1. Gene gun
                                                                                                                                                                                                                                                                                                                                                        1. Electroporation
                                                                                                                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                                                                                                                          2. Middle East and Africa Neoantigen Cancer Vaccine Market, By Application
                                                                                                                                                                                                                                                                                                                                                            1. Lung
                                                                                                                                                                                                                                                                                                                                                              1. Melanoma
                                                                                                                                                                                                                                                                                                                                                                1. Gastrointestinal
                                                                                                                                                                                                                                                                                                                                                                  1. Brain cancer
                                                                                                                                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                                                                                                                                    2. UAE
                                                                                                                                                                                                                                                                                                                                                                      1. UAE Neoantigen Cancer Vaccine Market, By Product
                                                                                                                                                                                                                                                                                                                                                                        1. Personalised neo-antigen vaccine
                                                                                                                                                                                                                                                                                                                                                                          1. Off-the-shelf neoantigen vaccine
                                                                                                                                                                                                                                                                                                                                                                          2. UAE Neoantigen Cancer Vaccine Market, By Neoantigen Type
                                                                                                                                                                                                                                                                                                                                                                            1. Synthetic Long Peptide
                                                                                                                                                                                                                                                                                                                                                                              1. Nucleic acid
                                                                                                                                                                                                                                                                                                                                                                                1. Dendritic cell
                                                                                                                                                                                                                                                                                                                                                                                  1. Tumour cell
                                                                                                                                                                                                                                                                                                                                                                                  2. UAE Neoantigen Cancer Vaccine Market, By Route of Administration
                                                                                                                                                                                                                                                                                                                                                                                    1. Intravenous
                                                                                                                                                                                                                                                                                                                                                                                      1. Intramuscular
                                                                                                                                                                                                                                                                                                                                                                                        1. Transdermal
                                                                                                                                                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                                                                                                                                                          2. UAE Neoantigen Cancer Vaccine Market, By Cell
                                                                                                                                                                                                                                                                                                                                                                                            1. Autologous
                                                                                                                                                                                                                                                                                                                                                                                              1. Allogenic
                                                                                                                                                                                                                                                                                                                                                                                              2. UAE Neoantigen Cancer Vaccine Market, By Technology
                                                                                                                                                                                                                                                                                                                                                                                                1. RNA Sequencing
                                                                                                                                                                                                                                                                                                                                                                                                  1. Whole Genome Sequencing
                                                                                                                                                                                                                                                                                                                                                                                                    1. HLA Typing
                                                                                                                                                                                                                                                                                                                                                                                                    2. UAE Neoantigen Cancer Vaccine Market, By Delivery Mechanism
                                                                                                                                                                                                                                                                                                                                                                                                      1. Liposomes
                                                                                                                                                                                                                                                                                                                                                                                                        1. Virosomes
                                                                                                                                                                                                                                                                                                                                                                                                          1. Gene gun
                                                                                                                                                                                                                                                                                                                                                                                                            1. Electroporation
                                                                                                                                                                                                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                                                                                                                                                                                                              2. UAE Neoantigen Cancer Vaccine Market, By Application
                                                                                                                                                                                                                                                                                                                                                                                                                1. Lung
                                                                                                                                                                                                                                                                                                                                                                                                                  1. Melanoma
                                                                                                                                                                                                                                                                                                                                                                                                                    1. Gastrointestinal
                                                                                                                                                                                                                                                                                                                                                                                                                      1. Brain cancer
                                                                                                                                                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                                                                                                                                                                      1. LATAM Neoantigen Cancer Vaccine Market, By Product
                                                                                                                                                                                                                                                                                                                                                                                                                        1. Personalised neo-antigen vaccine
                                                                                                                                                                                                                                                                                                                                                                                                                          1. Off-the-shelf neoantigen vaccine
                                                                                                                                                                                                                                                                                                                                                                                                                          2. LATAM Neoantigen Cancer Vaccine Market, By Neoantigen Type
                                                                                                                                                                                                                                                                                                                                                                                                                            1. Synthetic Long Peptide
                                                                                                                                                                                                                                                                                                                                                                                                                              1. Nucleic acid
                                                                                                                                                                                                                                                                                                                                                                                                                                1. Dendritic cell
                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Tumour cell
                                                                                                                                                                                                                                                                                                                                                                                                                                  2. LATAM Neoantigen Cancer Vaccine Market, By Route of Administration
                                                                                                                                                                                                                                                                                                                                                                                                                                    1. Intravenous
                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Intramuscular
                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Transdermal
                                                                                                                                                                                                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                                                                                                                                                                                                          2. LATAM Neoantigen Cancer Vaccine Market, By Cell
                                                                                                                                                                                                                                                                                                                                                                                                                                            1. Autologous
                                                                                                                                                                                                                                                                                                                                                                                                                                              1. Allogenic
                                                                                                                                                                                                                                                                                                                                                                                                                                              2. LATAM Neoantigen Cancer Vaccine Market, By Technology
                                                                                                                                                                                                                                                                                                                                                                                                                                                1. RNA Sequencing
                                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Whole Genome Sequencing
                                                                                                                                                                                                                                                                                                                                                                                                                                                    1. HLA Typing
                                                                                                                                                                                                                                                                                                                                                                                                                                                    2. LATAM Neoantigen Cancer Vaccine Market, By Delivery Mechanism
                                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Liposomes
                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Virosomes
                                                                                                                                                                                                                                                                                                                                                                                                                                                          1. Gene gun
                                                                                                                                                                                                                                                                                                                                                                                                                                                            1. Electroporation
                                                                                                                                                                                                                                                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                                                                                                                                                                                                                                                              2. LATAM Neoantigen Cancer Vaccine Market, By Application
                                                                                                                                                                                                                                                                                                                                                                                                                                                                1. Lung
                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Melanoma
                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1. Gastrointestinal
                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Brain cancer
                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2. Brazil
                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1. Brazil Neoantigen Cancer Vaccine Market, By Product
                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1. Personalised neo-antigen vaccine
                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1. Off-the-shelf neoantigen vaccine
                                                                                                                                                                                                                                                                                                                                                                                                                                                                              2. Brazil Neoantigen Cancer Vaccine Market, By Neoantigen Type
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1. Synthetic Long Peptide
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Nucleic acid
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1. Dendritic cell
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Tumour cell
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      2. Brazil Neoantigen Cancer Vaccine Market, By Route of Administration
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Intravenous
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1. Intramuscular
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1. Transdermal
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              2. Brazil Neoantigen Cancer Vaccine Market, By Cell
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1. Autologous
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Allogenic
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2. Brazil Neoantigen Cancer Vaccine Market, By Technology
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1. RNA Sequencing
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Whole Genome Sequencing
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. HLA Typing
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2. Brazil Neoantigen Cancer Vaccine Market, By Delivery Mechanism
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1. Liposomes
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1. Virosomes
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1. Gene gun
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1. Electroporation
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2. Brazil Neoantigen Cancer Vaccine Market, By Application
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1. Lung
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Melanoma
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Gastrointestinal
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1. Brain cancer
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          2. Mexico
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          3. Argentina
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          4. Chile
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          5. Colombia
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          6. Rest of LATAM

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Related Reports

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      The global tool steel market size was valued at USD 5.07 billion in 2021. It is estimated to reach an expected value of USD 8.16 billion by 2030 at a CAGR of 5.3% during the forecast period (2022-2030).  Tool steels are from the carbon ste
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Buy Now
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      The global sleep apnea devices market size was valued at USD 4,584.90 million in 2022. It is expected to reach USD 9,405.63 million by 2031, growing at a CAGR of 8.3% during the forecast period (2023–2031). Sleep apnea is a sleeping disorder c
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Buy Now
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      The global fire sprinkler market size was valued at USD 12.49 Billion in 2021. It is expected to reach USD 22.26 Billion by 2030, growing at a CAGR of 7.49% during the forecast period (2022–2030). A fire sprinkler system is a straightforward y
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Buy Now
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      The global print on demand market was valued at USD 6.3 billion in 2022. It is projected to reach USD 45.6 billion by 2031, growing at a CAGR of 25.3% during the forecast period (2023–2031). E-commerce expansion and the growing trend of online
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Buy Now
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      The global platinum market size was valued at USD 7.72 billion in 2022 and is projected to reach USD 11.95 billion by 2031 at a CAGR of 5.13% from 2023 to 2031. Platinum is a crucial component in catalytic converters used to reduce harmful
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Buy Now

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Purchase Benefits

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      • Completely customizable scope
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      • Dedicated account manager
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      • Permission to print the report

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      We are featured on :

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      www.straitsresearch.com
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      © Copyright . All rights Reserved.